KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Equity (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 16 years of Return on Equity data on record, last reported at 0.41% in Q3 2025.

  • For Q3 2025, Return on Equity fell 36.0% year-over-year to 0.41%; the TTM value through Sep 2025 reached 0.41%, down 36.0%, while the annual FY2024 figure was 0.93%, 87.0% down from the prior year.
  • Return on Equity reached 0.41% in Q3 2025 per IONS's latest filing, up from 0.49% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.06% in Q3 2022 and bottomed at 1.1% in Q3 2023.
  • Average Return on Equity over 5 years is 0.4%, with a median of 0.46% recorded in 2022.
  • Peak YoY movement for Return on Equity: plummeted -116bps in 2023, then skyrocketed 105bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then tumbled by -22852bps to 0.46% in 2022, then surged by 81bps to 0.09% in 2023, then tumbled by -708bps to 0.73% in 2024, then soared by 43bps to 0.41% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.41% in Q3 2025, 0.49% in Q2 2025, and 0.86% in Q1 2025.